BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, November 25, 2024
See today's BioWorld MedTech
Home
» Brexit could cost U.K. med-tech firms substantial time, money
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Brexit could cost U.K. med-tech firms substantial time, money
April 12, 2016
By
John Brosky
No Comments
PARIS – Leaving the European Union will cost the United Kingdom £100 billion pounds (US$142.5 billion) in gross domestic product and 950,000 jobs by 2020, according to the London-based Confederation of British Industry.
BioWorld MedTech